Lipomatosis, Multiple Symmetrical: Clinical Trials

3 trials for Lipomatosis, Multiple Symmetrical, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1
Phase 31Unknown 1

Follow Lipomatosis, Multiple Symmetrical: new trials by email Literature Review of Lipomatosis, Multiple Symmetrical trials Research Report on Lipomatosis, Multiple Symmetrical

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)
Metreleptin - Lipomatosis, Multiple Symmetrical
Phase 2Active not recruitingUniversity of Michigan42023-08-012025-06-12
Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study
Hydrocortisone, Placebo - Symmetric Lipomatoses, Multiple
Phase 3UnknownErasmus Medical Center12021-06-012021-03-29
Insight Into Subcutaneous Adipose Tissue Disorders
Lipedema, Dercum's Disease
UnknownUniversity of Arizona5002016-06-012017-09-15

Narrower conditions

Adiposis Dolorosa (1)  ·  Familial Multiple Lipomatosis (1)  ·  Lipedema (1)  ·  Lipoma (1)

Broader conditions

Lipid Metabolism Disorders (3)  ·  Lipomatosis (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Adipose Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)

Interventions

Hydrocortisone (1)  ·  metreleptin (1)

Sponsors

Erasmus Medical Center (1)  ·  University of Arizona (1)  ·  University of Michigan (1)

Countries

United States (2)  ·  Netherlands (1)

Top investigators

Elif Oral (1)  ·  Karen L Herbst, PhD, MD (1)  ·  Laura de Graaff, MD, PhD (1)

Results publications

PMID 33786515, PMID 40097137